Risk Analysis
Welcome.
Sign in or register.
Refer A Friend
|
Contact Us
Providing investors with the
tools to make informed decisions.
Providing investors with the
tools to make informed decisions.
Tracking 1050 U.S. listed China Stocks and Counting...
Tracking 1535 U.S. Stocks and Counting...
Home
Market Activity
Shell Activity
Research
Message Boards
GeoBlog
About
GeoResearch
GeoBargains
GeoSpecials
Guidance
Make Goods
Penny Stocks
Recent Additions
All Companies
Biostar Pharmaceuticals (NASDAQ:BSPM)
GeoProfile
Overview
GeoResearch
Message Board
Alerts Log
GeoWire Log
Third party data
Quote
Level II
Historical Prices
Options
Profile
Financials
Charts
News
Filings
Insiders
Do you represent this company?
Learn how we can help increase your exposure to investors.
All
Research
Acquisition Activity
Analyst Reports
CFO Trail
Comments & Business Outlook
GeoSpecial Notes
Investor Alert
Investor Presentations
Liquidity Requirements
Notable Share Transactions
Share Structure
Special Situations
Monday, May 16, 2011
Based on our current plans for the next 12 months, we anticipate that the sales of the Company’s pharmaceutical products will be the primary organic source of funds for future operating activities in 2011. However, to
fund continued expansion
of our operation and extend our reach to broader markets, and to acquire additional entities, as we may deem appropriate, we may rely on bank borrowing, if available, as well as
capital raises
.
Permalink
Post a comment
Monday, November 15, 2010
As of September 30, 2010
, we had cash and cash equivalents of approximately $16.6 million. We believe our existing cash and cash equivalents will be sufficient to maintain our operations at present level for at least the next twelve months.
Permalink
Post a comment
Post Comment
Quick Facts
Industry
Pharma
Web site
biostarpharma...